Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
18 New method of assessing tumor heterogeneity utilizing both circulating tumor DNA and tissue DNA to predict the response to immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
